サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1786878

バイオサージェリー市場、規模、シェア、動向、産業分析レポート：製品別、用途別、地域別、2025年～2034年の市場予測

Biosurgery Market Size, Share, Trends, Industry Analysis Report By Product (Surgical Sealants, Hemostatic Agents, Adhesion Barriers, Soft Tissue Attachments, Bone Graft Attachments, Others), By Application, By Region - Market Forecast, 2025-2034

出版日
ページ情報
英文 129 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.50円
バイオサージェリー市場、規模、シェア、動向、産業分析レポート：製品別、用途別、地域別、2025年～2034年の市場予測
出版日: 2025年07月01日
発行: Polaris Market Research
ページ情報: 英文 129 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、バイオサージェリー市場規模は2034年までに410億米ドルに達する見込みです。このレポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

バイオサージェリーは、外科手術をサポートするために天然の生物学的生物や物質を利用することで、治癒を促進し、合併症を最小限に抑える専門的な医療分野です。外科医は、ウジ虫によるデブリードマン、ヒル、酵素、その他の生物学的薬剤を用いて、創傷の治療、死組織の除去、血流の改善を行う。これらの方法は、従来の外科手術に代わる低侵襲な方法であり、健康上のリスクから従来の手術を受けることができない患者にとって有益です。

バイオサージェリーには、従来の手術に比べて感染率が低い、傷跡が残りにくい、回復が早いなどの利点があります。また、免疫力が低下している患者や麻酔合併症のリスクが高い患者にもメリットがあります。ただし、特定の生物学的薬剤にアレルギー反応や心理的不快感を覚える人もいるため、施術者は慎重に候補者を選ぶ必要があります。

バイオサージェリー市場レポートハイライト

製品別では、外科手術用シーラント部門が2024年に28.38％の売上シェアを占めました。これは、心臓血管、肺、肝手術など幅広い外科専門分野での使用が増加しているためです。

製品別では、軟組織アタッチメント分野は、スポーツ傷害症例数の急増、整形外科的再建、軟組織修復処置のため、今後数年間は堅調なペースで成長すると予測されています。

用途別では、効果的な出血コントロールと組織密封を必要とする腹部、消化管、肝胆膵処置の普及が進んでいるため、一般外科が2024年の収益市場シェアを独占しました。

心臓血管外科分野は、心臓疾患の有病率の増加、開心術や血管手術の増加により、今後数年間で急速に成長すると予測されています。

北米は2024年のバイオサージェリー世界市場で51.16％のシェアを占めています。この優位性は、慢性疾患の有病率の増加と高齢化に起因しています。

米国は2024年に北米バイオサージェリー市場シェアの77.79%を占めたが、これは高いヘルスケア支出と低侵襲手技への強い注目によるものです。

アジア太平洋地域の市場は、ヘルスケアインフラの急速な改善と外科手術の増加により、今後数年間は堅調なペースで成長すると予測されています。

インド市場は、高度な創傷ケアと外科手術用止血材に対する意識の高まりにより拡大しています。

欧州市場は、確立されたヘルスケアシステムと手術件数の多さから、2034年にはかなりの市場シェアを占めると予測されています。

世界の主要市場プレーヤーには、Artivion, Inc.、Aroa Biosurgery、B. Braun SE、Baxter、BD、INTEGRA LIFESCIENCES、Johnson &Johnson Services, Inc.、Medtronic、Pfizer Inc.、Sanofi、Strykerなどがあります。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のバイオサージェリー市場の洞察

  • 市場スナップショット
  • バイオサージェリー市場力学
    • 促進要因と機会
      • 低侵襲手術の需要増加
      • 慢性疾患の増加
    • 抑制要因と課題
      • 高コスト
  • PESTEL分析
  • バイオサージェリー市場の動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界のバイオサージェリー市場：製品別

  • 主な調査結果
  • イントロダクション
  • 外科手術用シーラント
  • 止血剤
  • 癒着防止バリア
  • 軟部組織付着部
  • 骨移植アタッチメント
  • その他

第6章 世界のバイオサージェリー市場：用途別

  • 主な調査結果
  • イントロダクション
  • 一般外科
  • 整形外科
  • 心臓血管外科
  • 神経外科
  • その他

第7章 世界のバイオサージェリー市場：地域別

  • 主な調査結果
  • イントロダクション
    • バイオサージェリー市場評価：地域別、2020～2034年
  • 北米
    • 北米：製品別、2020～2034年
    • 北米：用途別、2020～2034年
    • 米国
    • カナダ
  • 欧州
    • 欧州：製品別、2020～2034年
    • 欧州：用途別、2020～2034年
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他欧州
  • アジア太平洋地域
    • アジア太平洋地域：製品別、2020～2034年
    • アジア太平洋地域：用途別、2020～2034年
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ
    • 中東・アフリカ：製品別、2020～2034年
    • 中東・アフリカ：用途別、2020～2034年
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ
  • ラテンアメリカ
    • ラテンアメリカ：製品別、2020～2034年
    • ラテンアメリカ：用途別、2020～2034年
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ

第8章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第9章 企業プロファイル

  • Artivion, Inc.
  • Aroa Biosurgery
  • B. Braun SE
  • Baxter
  • BD
  • INTEGRA LIFESCIENCES
  • Johnson & Johnson Services, Inc.
  • Medtronic
  • Sanofi
  • Pfizer Inc.
  • Stryker
図表

List of Tables:

  • Table 1 Global Biosurgery Market, by Product, 2020-2034 (USD Billion)
  • Table 2 Global Biosurgery Market, by Application, 2020-2034 (USD Billion)
  • Table 3 North America: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  • Table 4 North America: Biosurgery Market, by Application, 2020-2034 (USD Billion)
  • Table 5 U.S.: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  • Table 6 U.S.: Biosurgery Market, by Application, 2020-2034 (USD Billion)
  • Table 7 Canada: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  • Table 8 Canada: Biosurgery Market, by Application, 2020-2034 (USD Billion)
  • Table 9 Europe: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  • Table 10 Europe: Biosurgery Market, by Application, 2020-2034 (USD Billion)
  • Table 11 UK: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  • Table 12 UK: Biosurgery Market, by Application, 2020-2034 (USD Billion)
  • Table 13 France: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  • Table 14 France: Biosurgery Market, by Application, 2020-2034 (USD Billion)
  • Table 15 Germany: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  • Table 16 Germany: Biosurgery Market, by Application, 2020-2034 (USD Billion)
  • Table 17 Italy: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  • Table 18 Italy: Biosurgery Market, by Application, 2020-2034 (USD Billion)
  • Table 19 Spain: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  • Table 20 Spain: Biosurgery Market, by Application, 2020-2034 (USD Billion)
  • Table 21 Netherlands: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  • Table 22 Netherlands: Biosurgery Market, by Application, 2020-2034 (USD Billion)
  • Table 23 Russia: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  • Table 24 Russia: Biosurgery Market, by Application, 2020-2034 (USD Billion)
  • Table 25 Rest of Europe: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  • Table 26 Rest of Europe: Biosurgery Market, by Application, 2020-2034 (USD Billion)
  • Table 27 Asia Pacific: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  • Table 28 Asia Pacific: Biosurgery Market, by Application, 2020-2034 (USD Billion)
  • Table 29 China: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  • Table 30 China: Biosurgery Market, by Application, 2020-2034 (USD Billion)
  • Table 31 India: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  • Table 32 India: Biosurgery Market, by Application, 2020-2034 (USD Billion)
  • Table 33 Malaysia: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  • Table 34 Malaysia: Biosurgery Market, by Application, 2020-2034 (USD Billion)
  • Table 35 Japan: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  • Table 36 Japan: Biosurgery Market, by Application, 2020-2034 (USD Billion)
  • Table 37 Indonesia: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  • Table 38 Indonesia: Biosurgery Market, by Application, 2020-2034 (USD Billion)
  • Table 39 South Korea: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  • Table 40 South Korea: Biosurgery Market, by Application, 2020-2034 (USD Billion)
  • Table 41 Australia: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  • Table 42 Australia: Biosurgery Market, by Application, 2020-2034 (USD Billion)
  • Table 43 Rest of Asia Pacific: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  • Table 44 Rest of Asia Pacific: Biosurgery Market, by Application, 2020-2034 (USD Billion)
  • Table 45 Middle East & Africa: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  • Table 46 Middle East & Africa: Biosurgery Market, by Application, 2020-2034 (USD Billion)
  • Table 47 Saudi Arabia: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  • Table 48 Saudi Arabia: Biosurgery Market, by Application, 2020-2034 (USD Billion)
  • Table 49 UAE: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  • Table 50 UAE: Biosurgery Market, by Application, 2020-2034 (USD Billion)
  • Table 51 Israel: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  • Table 52 Israel: Biosurgery Market, by Application, 2020-2034 (USD Billion)
  • Table 53 South Africa: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  • Table 54 South Africa: Biosurgery Market, by Application, 2020-2034 (USD Billion)
  • Table 55 Rest of Middle East & Africa: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  • Table 56 Rest of Middle East & Africa: Biosurgery Market, by Application, 2020-2034 (USD Billion)
  • Table 57 Latin America: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  • Table 58 Latin America: Biosurgery Market, by Application, 2020-2034 (USD Billion)
  • Table 59 Mexico: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  • Table 60 Mexico: Biosurgery Market, by Application, 2020-2034 (USD Billion)
  • Table 61 Brazil: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  • Table 62 Brazil: Biosurgery Market, by Application, 2020-2034 (USD Billion)
  • Table 63 Argentina: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  • Table 64 Argentina: Biosurgery Market, by Application, 2020-2034 (USD Billion)
  • Table 65 Rest of Latin America: Biosurgery Market, by Product, 2020-2034 (USD Billion)
  • Table 66 Rest of Latin America: Biosurgery Market, by Application, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Biosurgery Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Biosurgery Market, by Product, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Application
  • Figure 9. Global Biosurgery Market, by Application, 2024 & 2034 (USD Billion)
目次
Product Code: PM5930

The biosurgery market size is expected to reach USD 41.00 billion by 2034, according to a new study by Polaris Market Research. The report "Biosurgery Market Share, Size, Trends, Industry Analysis Report By Product (Surgical Sealants, Hemostatic Agents, Adhesion Barriers, Soft Tissue Attachments, Bone Graft Attachments, Others), By Application, By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Biosurgery is a specialized medical field that utilizes natural biological organisms or substances to support surgical procedures, thereby promoting healing and minimizing complications. Surgeons employ maggot debridement, leeches, enzymes, or other biological agents to treat wounds, remove dead tissue, or improve blood flow. These methods offer a minimally invasive alternative to traditional surgery, benefiting patients who cannot undergo conventional procedures due to health risks.

Biosurgery offers several advantages, including lower infection rates, reduced scarring, and faster recovery times compared to conventional surgery. It also benefits patients with compromised immune systems or those at high risk for anesthesia complications. However, practitioners must carefully select candidates, as some individuals may experience allergic reactions or psychological discomfort with certain biological agents.

Biosurgery Market Report Highlights

In terms of product, the surgical sealants segment accounted for 28.38% revenue share in 2024 due to their increasing use across a wide range of surgical specialties, including cardiovascular, pulmonary, and hepatic procedures.

The soft tissue attachments segment, based on product, is projected to grow at a robust pace in the coming years, owing to the surge in the number of sports injury cases, orthopedic reconstructions, and soft tissue repair procedures.

Based on application, the general surgery dominated the revenue market share in 2024 due to the rising penetration of abdominal, gastrointestinal, and hepatobiliary procedures that require effective bleeding control and tissue sealing.

The cardiovascular surgery segment, in terms of application, is projected to grow at a rapid pace in the coming years, driven by the increasing prevalence of heart diseases and the rising number of open-heart and vascular procedures.

North America accounted for 51.16% share of the global biosurgery market in 2024. This dominance is attributed to the growing prevalence of chronic diseases and an aging population.

The U.S. held 77.79% of the North America biosurgery market share in 2024 due to high healthcare spending and a strong focus on minimally invasive procedures.

The market in Asia Pacific is projected to grow at a robust pace in the coming years, owing to the rapidly improving healthcare infrastructure and increasing surgical procedures.

The market in India is expanding due to rising awareness of advanced wound care and surgical hemostats.

The market in Europe is projected to hold a substantial market share in 2034 due to established healthcare systems and high surgical volumes.

A few global key market players include Artivion, Inc.; Aroa Biosurgery; B. Braun SE; Baxter; BD; INTEGRA LIFESCIENCES; Johnson & Johnson Services, Inc.; Medtronic; Pfizer Inc.; Sanofi; and Stryker.

Polaris Market Research has segmented the biosurgery market report on the basis of product, application, and region:

By Product Outlook (Revenue, USD Billion, 2020-2034)

Surgical Sealants

Hemostatic Agents

Adhesion Barriers

Soft Tissue Attachments

Bone Graft Attachments

Others

By Application Outlook (Revenue, USD Billion, 2020-2034)

General Surgery

Orthopedic Surgery

Cardiovascular Surgery

Neurological Surgery

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Biosurgery Market Insights

  • 4.1. Biosurgery Market - Market Snapshot
  • 4.2. Biosurgery Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Demand for Minimally Invasive Surgical Procedures
      • 4.2.1.2. Growing Prevalence of Chronic Diseases
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Biosurgery Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Biosurgery Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Biosurgery Market, by Product, 2020-2034 (USD Billion)
  • 5.3. Surgical Sealants
    • 5.3.1. Global Biosurgery Market, by Surgical Sealants, by Region, 2020-2034 (USD Billion)
  • 5.4. Hemostatic Agents
    • 5.4.1. Global Biosurgery Market, by Hemostatic Agents, by Region, 2020-2034 (USD Billion)
  • 5.5. Adhesion Barriers
    • 5.5.1. Global Biosurgery Market, by Adhesion Barriers, by Region, 2020-2034 (USD Billion)
  • 5.6. Soft Tissue Attachments
    • 5.6.1. Global Biosurgery Market, by Soft Tissue Attachments, by Region, 2020-2034 (USD Billion)
  • 5.7. Bone Graft Attachments
    • 5.7.1. Global Biosurgery Market, by Bone Graft Attachments, by Region, 2020-2034 (USD Billion)
  • 5.8. Others
    • 5.8.1. Global Biosurgery Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Biosurgery Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Biosurgery Market, by Application, 2020-2034 (USD Billion)
  • 6.3. General Surgery
    • 6.3.1. Global Biosurgery Market, by General Surgery, by Region, 2020-2034 (USD Billion)
  • 6.4. Orthopedic Surgery
    • 6.4.1. Global Biosurgery Market, by Orthopedic Surgery, by Region, 2020-2034 (USD Billion)
  • 6.5. Cardiovascular Surgery
    • 6.5.1. Global Biosurgery Market, by Cardiovascular Surgery, by Region, 2020-2034 (USD Billion)
  • 6.6. Neurological Surgery
    • 6.6.1. Global Biosurgery Market, by Neurological Surgery, by Region, 2020-2034 (USD Billion)
  • 6.7. Others
    • 6.7.1. Global Biosurgery Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Biosurgery Market, by Geography

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Biosurgery Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 7.3. Biosurgery Market - North America
    • 7.3.1. North America: Biosurgery Market, by Product, 2020-2034 (USD Billion)
    • 7.3.2. North America: Biosurgery Market, by Application, 2020-2034 (USD Billion)
    • 7.3.3. Biosurgery Market - U.S.
      • 7.3.3.1. U.S.: Biosurgery Market, by Product, 2020-2034 (USD Billion)
      • 7.3.3.2. U.S.: Biosurgery Market, by Application, 2020-2034 (USD Billion)
    • 7.3.4. Biosurgery Market - Canada
      • 7.3.4.1. Canada: Biosurgery Market, by Product, 2020-2034 (USD Billion)
      • 7.3.4.2. Canada: Biosurgery Market, by Application, 2020-2034 (USD Billion)
  • 7.4. Biosurgery Market - Europe
    • 7.4.1. Europe: Biosurgery Market, by Product, 2020-2034 (USD Billion)
    • 7.4.2. Europe: Biosurgery Market, by Application, 2020-2034 (USD Billion)
    • 7.4.3. Biosurgery Market - UK
      • 7.4.3.1. UK: Biosurgery Market, by Product, 2020-2034 (USD Billion)
      • 7.4.3.2. UK: Biosurgery Market, by Application, 2020-2034 (USD Billion)
    • 7.4.4. Biosurgery Market - France
      • 7.4.4.1. France: Biosurgery Market, by Product, 2020-2034 (USD Billion)
      • 7.4.4.2. France: Biosurgery Market, by Application, 2020-2034 (USD Billion)
    • 7.4.5. Biosurgery Market - Germany
      • 7.4.5.1. Germany: Biosurgery Market, by Product, 2020-2034 (USD Billion)
      • 7.4.5.2. Germany: Biosurgery Market, by Application, 2020-2034 (USD Billion)
    • 7.4.6. Biosurgery Market - Italy
      • 7.4.6.1. Italy: Biosurgery Market, by Product, 2020-2034 (USD Billion)
      • 7.4.6.2. Italy: Biosurgery Market, by Application, 2020-2034 (USD Billion)
    • 7.4.7. Biosurgery Market - Spain
      • 7.4.7.1. Spain: Biosurgery Market, by Product, 2020-2034 (USD Billion)
      • 7.4.7.2. Spain: Biosurgery Market, by Application, 2020-2034 (USD Billion)
    • 7.4.8. Biosurgery Market - Netherlands
      • 7.4.8.1. Netherlands: Biosurgery Market, by Product, 2020-2034 (USD Billion)
      • 7.4.8.2. Netherlands: Biosurgery Market, by Application, 2020-2034 (USD Billion)
    • 7.4.9. Biosurgery Market - Russia
      • 7.4.9.1. Russia: Biosurgery Market, by Product, 2020-2034 (USD Billion)
      • 7.4.9.2. Russia: Biosurgery Market, by Application, 2020-2034 (USD Billion)
    • 7.4.10. Biosurgery Market - Rest of Europe
      • 7.4.10.1. Rest of Europe: Biosurgery Market, by Product, 2020-2034 (USD Billion)
      • 7.4.10.2. Rest of Europe: Biosurgery Market, by Application, 2020-2034 (USD Billion)
  • 7.5. Biosurgery Market - Asia Pacific
    • 7.5.1. Asia Pacific: Biosurgery Market, by Product, 2020-2034 (USD Billion)
    • 7.5.2. Asia Pacific: Biosurgery Market, by Application, 2020-2034 (USD Billion)
    • 7.5.3. Biosurgery Market - China
      • 7.5.3.1. China: Biosurgery Market, by Product, 2020-2034 (USD Billion)
      • 7.5.3.2. China: Biosurgery Market, by Application, 2020-2034 (USD Billion)
    • 7.5.4. Biosurgery Market - India
      • 7.5.4.1. India: Biosurgery Market, by Product, 2020-2034 (USD Billion)
      • 7.5.4.2. India: Biosurgery Market, by Application, 2020-2034 (USD Billion)
    • 7.5.5. Biosurgery Market - Malaysia
      • 7.5.5.1. Malaysia: Biosurgery Market, by Product, 2020-2034 (USD Billion)
      • 7.5.5.2. Malaysia: Biosurgery Market, by Application, 2020-2034 (USD Billion)
    • 7.5.6. Biosurgery Market - Japan
      • 7.5.6.1. Japan: Biosurgery Market, by Product, 2020-2034 (USD Billion)
      • 7.5.6.2. Japan: Biosurgery Market, by Application, 2020-2034 (USD Billion)
    • 7.5.7. Biosurgery Market - Indonesia
      • 7.5.7.1. Indonesia: Biosurgery Market, by Product, 2020-2034 (USD Billion)
      • 7.5.7.2. Indonesia: Biosurgery Market, by Application, 2020-2034 (USD Billion)
    • 7.5.8. Biosurgery Market - South Korea
      • 7.5.8.1. South Korea: Biosurgery Market, by Product, 2020-2034 (USD Billion)
      • 7.5.8.2. South Korea: Biosurgery Market, by Application, 2020-2034 (USD Billion)
    • 7.5.9. Biosurgery Market - Australia
      • 7.5.9.1. Australia: Biosurgery Market, by Product, 2020-2034 (USD Billion)
      • 7.5.9.2. Australia: Biosurgery Market, by Application, 2020-2034 (USD Billion)
    • 7.5.10. Biosurgery Market - Rest of Asia Pacific
      • 7.5.10.1. Rest of Asia Pacific: Biosurgery Market, by Product, 2020-2034 (USD Billion)
      • 7.5.10.2. Rest of Asia Pacific: Biosurgery Market, by Application, 2020-2034 (USD Billion)
  • 7.6. Biosurgery Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Biosurgery Market, by Product, 2020-2034 (USD Billion)
    • 7.6.2. Middle East & Africa: Biosurgery Market, by Application, 2020-2034 (USD Billion)
    • 7.6.3. Biosurgery Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Biosurgery Market, by Product, 2020-2034 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Biosurgery Market, by Application, 2020-2034 (USD Billion)
    • 7.6.4. Biosurgery Market - UAE
      • 7.6.4.1. UAE: Biosurgery Market, by Product, 2020-2034 (USD Billion)
      • 7.6.4.2. UAE: Biosurgery Market, by Application, 2020-2034 (USD Billion)
    • 7.6.5. Biosurgery Market - Israel
      • 7.6.5.1. Israel: Biosurgery Market, by Product, 2020-2034 (USD Billion)
      • 7.6.5.2. Israel: Biosurgery Market, by Application, 2020-2034 (USD Billion)
    • 7.6.6. Biosurgery Market - South Africa
      • 7.6.6.1. South Africa: Biosurgery Market, by Product, 2020-2034 (USD Billion)
      • 7.6.6.2. South Africa: Biosurgery Market, by Application, 2020-2034 (USD Billion)
    • 7.6.7. Biosurgery Market - Rest of Middle East & Africa
      • 7.6.7.1. Rest of Middle East & Africa: Biosurgery Market, by Product, 2020-2034 (USD Billion)
      • 7.6.7.2. Rest of Middle East & Africa: Biosurgery Market, by Application, 2020-2034 (USD Billion)
  • 7.7. Biosurgery Market - Latin America
    • 7.7.1. Latin America: Biosurgery Market, by Product, 2020-2034 (USD Billion)
    • 7.7.2. Latin America: Biosurgery Market, by Application, 2020-2034 (USD Billion)
    • 7.7.3. Biosurgery Market - Mexico
      • 7.7.3.1. Mexico: Biosurgery Market, by Product, 2020-2034 (USD Billion)
      • 7.7.3.2. Mexico: Biosurgery Market, by Application, 2020-2034 (USD Billion)
    • 7.7.4. Biosurgery Market - Brazil
      • 7.7.4.1. Brazil: Biosurgery Market, by Product, 2020-2034 (USD Billion)
      • 7.7.4.2. Brazil: Biosurgery Market, by Application, 2020-2034 (USD Billion)
    • 7.7.5. Biosurgery Market - Argentina
      • 7.7.5.1. Argentina: Biosurgery Market, by Product, 2020-2034 (USD Billion)
      • 7.7.5.2. Argentina: Biosurgery Market, by Application, 2020-2034 (USD Billion)
    • 7.7.6. Biosurgery Market - Rest of Latin America
      • 7.7.6.1. Rest of Latin America: Biosurgery Market, by Product, 2020-2034 (USD Billion)
      • 7.7.6.2. Rest of Latin America: Biosurgery Market, by Application, 2020-2034 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Artivion, Inc.
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Aroa Biosurgery
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. B. Braun SE
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Baxter
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. BD
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. INTEGRA LIFESCIENCES
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Johnson & Johnson Services, Inc.
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Medtronic
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Sanofi
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Pfizer Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Stryker
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development